Skip to main content

TODAY: Former FDA Official Joins Legal, Public Health Experts and Protect Our Care to Discuss Disastrous Implications of Mifepristone Abortion Case

By April 10, 2023No Comments


Devastating Ruling Threatens Essential Reproductive Care and Entire U.S. Drug Approval Process

Washington, DC — On Monday, April 10, 2023 at 2:30 PM ET, Williams Schultz, former deputy FDA commissioner and HHS General Counsel, Lynn Goldman, Dean of the Milken Institute School of Public Health at George Washington University, and experienced Supreme Court and appellate lawyer Andy Pincus will join Protect Our Care to discuss the disastrous implications of Judge Matthew Kacsmaryk’s ruling to invalidate the FDA’s approval of mifepristone. Judge Kacysmaryk’s ruling puts at risk not only the use of mifepristone for safe and legal abortions for millions of American women, but it opens the door for the politically-motivated removal of other safe and effective drugs from the market — throwing the entire U.S. drug approval process into chaos.

During the call, speakers will discuss how the Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration lawsuit has wider implications for the health care system and sets a precedent for any judge to be able to overrule the evidence-based and scientific FDA medication approval process.


William Schultz, Partner, Zuckerman Spaeder, former Deputy Commissioner, FDA, former General Counsel, Department of Health and Human Services
Lynn R Goldman, MD, MS, MPH, Professor and Dean, Milken Institute School of Public Health, George Washington University
Andrew Pincus, Visiting Lecturer in Law at Yale Law School and experienced Supreme Court and appellate lawyer
Leslie Dach, Chair of Protect Our Care

WHAT: Virtual Press Conference 

WHERE: Register for the Event Here

WHEN: April 10, 2023 at 2:30 PM ET